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We analysed the relation between coffee consumption and hepatocellular carcinoma in two case-control studies conducted
between 1984 and 1998 in Italy and Greece, including 834 cases and 1912 controls. Compared to non coffee drinkers, the
multivariate odds ratio was 0.7 for drinkers of three or more cups per day.
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The possible relation between coffee drinking and the risk of
several cancers, particularly of cancers of the urinary bladder,
pancreas and colorectum, has been widely investigated. These have
shown a direct relation with bladder, an inverse one with colorec-
tum, but no consistent association with other major sites, including
liver cancer (IARC, 1991; Tavani and La Vecchia, 2000).
Coffee drinking has been inversely related to the risk of liver
cirrhosis in several studies (Klatsky and Armstrong, 1992; Klatsky
et al, 1993; Corrao et al, 1994, 2001; Gallus et al, 2002). Although
cirrhosis is a major correlate of hepatocellular carcinoma (Adami
et al, 1992; La Vecchia et al, 1998, Kuper et al, 2000), the relation
between coffee drinking and risk of hepatocellular carcinoma has
been examined in only two studies which provided, however, no
definite results. An Italian case-control study (La Vecchia et al,
1989), based on 151 cases with hepatocellular carcinoma, reported
a multivariate odds ratio (OR) of 0.78 for drinkers of 53 cups of
coffee per day, compared to non coffee drinkers. In a Greek case-
control study (Kuper et al, 2000), based on 333 cases, the age- and
sex- adjusted OR was 0.7 for drinkers of 520 cups per week
compared to non drinkers.
To clarify the role of coffee drinking in hepatocellular cancer, we
updated and re-analysed the Italian and Greek studies.
MATERIALS AND METHODS
Selection of cases and controls
The present data derived from two case-control studies of hepato-
cellular carcinoma. The first was conducted between 1984 and
1997, in a network of teaching and general hospitals in the Greater
Milan area (La Vecchia et al, 1989, 1998). Cases were 501 subjects
with incident, histologically confirmed hepatocellular carcinoma.
Of these, 378 were males and 123 were females; the age range
was 20 – 75 years, median age 60. Controls were 1552 patients with
acute non neoplastic conditions, unrelated to long-term changes in
diet or coffee drinking habit (i.e., gastritis or other chronic diges-
tive tract disorders), from the same catchment areas as the cases,
and admitted to the same hospitals. Of these, 1141 were males
and 411 were females; the age range was 18 – 75 years, median
age 56.
The second study was conducted between 1995 and 1998 in
three teaching hospitals from Athens (Kuper et al, 2000). Cases
were 333 subjects with incident hepatocellular carcinoma. Of these,
283 were males and 50 were females; the age range was 31 – 79
years, median age 65. Controls were 360 patients admitted to the
same hospitals as the cases, for injuries, or eye, ear, nose or throat
conditions. Of these, 298 were males and 62 were females; the age
range was 24 – 79 years, median age 65.
Thus, a total of 834 cases of hepatocellular carcinoma and 1912
controls were considered in the present analysis.
Data collection
Different structured questionnaires were utilised in the two studies
but both collected information on socio-demographic characteris-
tics, including education and occupation, a few indicator foods,
lifetime tobacco smoking and alcohol drinking, and anthropo-
metric measures. In the Italian questionnaire, a self-reported
medical history was available, including information on hepatitis,
liver cirrhosis and diabetes. In the Greek study, biological samples
were obtained from cases and controls to test for markers of infec-
tion with hepatitis B and C viruses, while a self-reported medical
history was available for diabetes and cirrhosis. With reference to
coffee consumption, the Italian questionnaire included data on
number of cups of coffee (mainly expresso and mocha) per day
during the year before the onset of the index disease, and duration
of the habit; the Greek study included three items for coffee
consumption (Greek coffee, instant coffee and filtered coffee).
For each item, the number of cups per week and the total duration
of the habit (in years) were elicited. Total daily coffee consumption
was computed summing up these three items.
Data analysis
ORs and the corresponding 95% confidence intervals (CI) were
derived from unconditional multiple logistic regression (Breslow
and Day, 1980). All the equations included terms for study, quin-
quennia of age and sex. Additional models included terms for
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education, body mass index (BMI), tobacco smoking, alcohol
drinking, diabetes and hepatitis.
RESULTS
Table 1 shows the distribution of hepatocellular carcioma cases and
controls according to sex, age and selected other variables. Cases
were more frequently less educated and heavy alcohol drinkers
than controls. Moreover, they had more frequently a history of
diabetes and hepatitis.
Table 2 shows the distribution of hepatocellular carcinoma cases
and controls, and the corresponding ORs according to level and
duration of regular coffee consumption. Compared to non coffee
drinkers, the OR for coffee drinkers was 0.8 (95% CI: 0.6 – 1.0),
and 0.6 (95% CI: 0.4 – 0.7) for drinkers of 53 cups per day (P
for trend 50.001). The inverse relation was consistent in the
Italian and Greek datasets. After allowance for alcohol drinking,
tobacco smoking and other potential confounding factors, these
figures became 1.0 and 0.7, and the trend in risk with number
of cups per day was significant. No association emerged with dura-
tion of coffee drinking, the OR being 0.8 for 40 years or more,
compared to non coffee drinkers. When the reference category
was set to subjects drinking 41 cup per day, the multivariate
ORs were 0.9 (95% CI: 0.7 – 1.1) for 2 and 0.7 (95% CI: 0.5 –
0.9) for 53 cups per day.
Table 3 gives the multivariate ORs for subsequent levels of coffee
consumption, as compared to 41 cup per day, in all subjects and
in strata of sex, age, education, BMI, alcohol and tobacco
consumption, and history of diabetes and hepatitis. Although
several of the ORs were not significant, in all strata ORs were
below unity for heavy coffee drinkers (53 cups per day), ranging
between 0.5 and 0.8.
DISCUSSION
This combined re-analysis suggests that coffee is inversely related to
the risk of liver cancer. Coffee consumption has been inversely
related to g-glutamyltransferase (GGT) activity in studies from
Italy, Finland, France, Japan and the United States (Kono et al,
1994; Tanaka et al, 1998; Casiglia et al, 1993; Poikolainen and
Vartiainen, 1997; Aubin et al, 1998; Sharp and Benowitz, 1995;
Sharp et al, 1999). GGT activity is a sensitive, but non-specific,
indicator of several liver diseases, including liver cirrhosis and
primary liver cancer (Penn and Worthington, 1983). Thus, it is
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Table 1 Distribution of 834 cases of hepatocellular carcinoma and 1912 controls
according to sex, age and other selected covariates. Italy and Greece, 1984 – 1998
Cases Controls
Covariates n % n %
Sex
Men 661 79.3 1439 75.3
Women 173 20.7 473 24.7
Age (years)
550 105 12.6 486 25.4
50 – 59 229 27.5 569 29.8
60 – 69 362 43.4 591 30.9
570 138 16.6 266 13.9
Educationa (years)
57 533 64.3 957 50.3
7 – 11 145 17.5 496 26.1
512 151 18.2 448 23.6
Body mass indexa (kg m72)
522 142 17.3 316 16.7
22 – 26 392 47.8 887 46.7
526 287 35.0 695 36.6
Alcohol consumption
Abstainers 254 30.3 453 23.7
Drinkers (drinks per day)
52 112 13.4 307 16.1
2 – 3 168 20.1 539 28.2
4 – 5 107 12.8 324 17.0
56 193 23.1 289 15.1
Tobacco consumption
Never smokers 303 36.3 711 37.2
Ex smokers 244 29.3 434 22.7
Current smokers
(cigarettes per day)
515 84 10.1 243 12.7
15 – 24 123 14.8 312 16.3
525 80 9.6 212 11.1
Diabetesa
No 695 83.5 1783 93.4
Yes 137 16.5 126 6.6
Hepatitisa
No 455 54.6 1830 96.1
Yes 379 45.4 75 3.9
aThe sum does not add up to the total because of some missing values.
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plausible that coffee drinking has a real effect in reducing incidence
of hepatocellular carcinoma, as suggested also by some experiments
on rats and hamsters (Tanaka et al, 1990).
In several case-control studies, coffee consumption showed an
inverse association with the incidence or diagnosis of liver cirrho-
sis, with significant trends in risk with dose and duration (Klatsky
and Armstrong, 1992; Klatsky et al, 1993; Corrao et al, 1994, 2001;
Gallus et al, 2002). Since liver cirrhosis is strongly related to the
incidence of hepatocellular carcinoma (Adami et al, 1992; La
Vecchia et al, 1998, Kuper et al, 2000), the apparent protective
effect of coffee consumption on hepatocellular carcinogenesis
may be due to its inverse relation with liver cirrhosis. A diagnosis
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Table 2 Distribution of 834 cases of hepatocellular carcinoma and 1912 controls, and odds ratio (OR), with 95% confidence interval (CI), according to
coffee consumption. Italy and Greece, 1984 – 1998
Greece Italy Total
Cases Controls ORa (95% CI) Cases Controls ORa (95% CI) Cases Controls ORa (95% CI) ORb (95% CI)
Coffee
Non drinkers 36 33 1c 93 223 1c 129 256 1c 1c
Drinkers 297 327 0.8 (0.5 – 1.3) 408 1329 0.7 (0.6 – 1.0) 705 1656 0.8 (0.6 – 1.0) 1.0 (0.7 – 1.3)
Coffee consumptiond
(cups per day)
1 81 95 0.8 (0.4 – 1.4) 150 337 1.0 (0.7 – 1.4) 231 432 0.9 (0.7 – 1.2) 1.2 (0.9 – 1.6)
2 150 143 0.9 (0.6 – 1.6) 142 439 0.7 (0.5 – 1.0) 292 582 0.8 (0.6 – 1.1) 1.0 (0.7 – 1.3)
53 64 88 0.6 (0.4 – 1.1) 114 549 0.5 (0.4 – 0.7) 178 637 0.6 (0.4 – 0.7) 0.7 (0.5 – 1.0)
w2trend 1.18 22.21 21.40 5.90
(P=0.277) (P50.001) (P50.001) (P=0.015)
Durationd (years)
530 54 58 0.9 (0.5 – 1.7) 107 522 0.7 (0.5 – 0.9) 161 580 0.7 (0.5 – 1.0) 1.0 (0.7 – 1.4)
30 – 39 76 87 0.7 (0.4 – 1.3) 167 481 0.8 (0.6 – 1.1) 243 568 0.8 (0.6 – 1.0) 1.0 (0.7 – 1.4)
540 167 182 0.8 (0.5 – 1.4) 127 319 0.7 (0.5 – 1.0) 294 501 0.8 (0.6 – 1.0) 1.0 (0.7 – 1.3)
w2trend 0.37 2.11 2.63 0.03
(P=0.541) (P=0.146) (P=0.105) (P=0.864)
aEstimates from multiple logistic regression equations, including terms for study, age and sex. bAfter further allowance for education, tobacco smoking, alcohol drinking, body mass
index and history of diabetes and hepatitis. cReference category. dThe sum does not add up to the total because of some missing values.
Table 3 Odds ratioa (OR) and 95% confidence interval (CI) of 834 cases of hepatocel-
lular carcinoma and 1912 controls, according to coffee consumption in strata of selected
covariates. Italy and Greece, 1984 – 1998
Coffee consumption (cups per day)
41 2 53
Sex
Men 1b 0.8 (0.6 – 1.1) 0.6 (0.4 – 0.8)
Women 1b 1.0 (0.6 – 1.6) 0.8 (0.5 – 1.4)
Age (years)
565 1b 0.9 (0.7 – 1.2) 0.7 (0.5 – 0.9)
565 1b 0.8 (0.6 – 1.2) 0.7 (0.4 – 1.1)
Education (years)
57 1b 0.8 (0.6 – 1.1) 0.6 (0.4 – 0.9)
57 1b 1.0 (0.7 – 1.5) 0.8 (0.5 – 1.2)
Body mass index (kg m72)
525 1b 0.9 (0.7 – 1.3) 0.8 (0.5 – 1.1)
525 1b 0.8 (0.5 – 1.1) 0.6 (0.4 – 0.8)
Alcohol intake (drinks per day)
54 1b 0.9 (0.7 – 1.2) 0.6 (0.4 – 0.9)
54 1b 0.8 (0.5 – 1.2) 0.7 (0.5 – 1.2)
Tobacco consumption
Never and ex smokers 1b 1.0 (0.7 – 1.3) 0.7 (0.5 – 0.9)
Current smokers 1b 0.7 (0.5 – 1.1) 0.6 (0.4 – 1.0)
Hepatitis
No 1b 0.9 (0.7 – 1.2) 0.7 (0.5 – 0.9)
Yes 1b 0.6 (0.3 – 1.1) 0.5 (0.2 – 1.3)
Diabetes
No 1b 0.9 (0.7 – 1.1) 0.7 (0.5 – 0.9)
Yes 1b 0.8 (0.4 – 1.4) 0.5 (0.2 – 1.2)
aEstimates from multiple logistic regression equations, including terms for study, age, sex, education,
body mass index, tobacco smoking, alcohol drinking, diabetes and hepatitis. bReference category.
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of cirrhosis was not histologically determined in all cases, although
most cases of liver cancer are likely to have some degree of cirrho-
sis. When the analysis was restricted to subjects who did not report
history of cirrhosis, the multivariate OR for drinkers of 53 cups of
coffee, compared to non coffee drinkers, was 0.8 (95% CI: 0.6 –
1.0), suggesting that clinical history of cirrhosis cannot entirely
account for this finding. Clinical history is however unlikely to
reflect the real prevalence of cirrhosis among cases.
Weaknesses and strengths of the studies have been discussed
elsewhere (Kuper et al, 2000; La Vecchia et al, 1989, 1998). Briefly,
it is possible that coffee drinking in hospital controls differs from
that of the general population (Rosenberg et al, 1981). However,
we included in the control groups patients with diseases unrelated,
or, at most, weakly positively related to the exposure under study.
Information on coffee, moreover, was not materially influenced by
hospital admission, and was satisfactorily reproducible (D’Avanzo
et al, 1996). As for other possible sources of bias, the catchment
areas of cases and controls were comparable, and participation
was almost complete, since less than 5% of cases and controls
refused the interview. Alcohol drinking and tobacco smoking
(factors associated to the risk of hepatocellular carcinoma and
coffee consumption) were allowed for in the analyses, together with
education and other possible confounding factors. Additional
allowance for selected indicator foods (vegetables and fruit) did
not materially modify any of the results. Moreover, the association
was observed in separate strata of tobacco smoking and alcohol
drinking as well as age, sex and other major covariates of interest.
In conclusion, the present study confirms in a large dataset the
hypothesis of an inverse association between coffee drinking and
liver cancer. However, the interpretation of this association and
the consequent inference on causality remains open.
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